GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senseonics Holdings Inc (AMEX:SENS) » Definitions » Cash Ratio

SENS (Senseonics Holdings) Cash Ratio : 2.10 (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Senseonics Holdings Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Senseonics Holdings's Cash Ratio for the quarter that ended in Sep. 2024 was 2.10.

Senseonics Holdings has a Cash Ratio of 2.10. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Senseonics Holdings's Cash Ratio or its related term are showing as below:

SENS' s Cash Ratio Range Over the Past 10 Years
Min: 0.02   Med: 2.88   Max: 11.39
Current: 2.1

During the past 10 years, Senseonics Holdings's highest Cash Ratio was 11.39. The lowest was 0.02. And the median was 2.88.

SENS's Cash Ratio is ranked better than
66.47% of 853 companies
in the Medical Devices & Instruments industry
Industry Median: 1.08 vs SENS: 2.10

Senseonics Holdings Cash Ratio Historical Data

The historical data trend for Senseonics Holdings's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senseonics Holdings Cash Ratio Chart

Senseonics Holdings Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.76 1.08 7.06 4.58 6.34

Senseonics Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.25 6.34 3.31 2.56 2.10

Competitive Comparison of Senseonics Holdings's Cash Ratio

For the Medical Devices subindustry, Senseonics Holdings's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Senseonics Holdings's Cash Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Senseonics Holdings's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Senseonics Holdings's Cash Ratio falls into.



Senseonics Holdings Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Senseonics Holdings's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=109.456/17.257
=6.34

Senseonics Holdings's Cash Ratio for the quarter that ended in Sep. 2024 is calculated as:

Cash Ratio (Q: Sep. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=74.481/35.509
=2.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Senseonics Holdings  (AMEX:SENS) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Senseonics Holdings Cash Ratio Related Terms

Thank you for viewing the detailed overview of Senseonics Holdings's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Senseonics Holdings Business Description

Traded in Other Exchanges
Address
20451 Seneca Meadows Parkway, Germantown, MD, USA, 20876-7005
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
Executives
Sharon Larkin director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Douglas A Roeder director 160 BOVET RD, SUITE 408, C/O DELPHI VENTURES, SAN MATEO CA 94402
Frederick T. Sullivan officer: Chief Financial Officer C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Mukul Jain officer: VP Operations, Qual & Reg 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Edward Fiorentino director 1350 KENNICOTT DRIVE, LAKE FOREST IL 60045
Mirasol Panlilio officer: VP Global Sales & Marketing 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Timothy T Goodnow director, officer: President & Chief Exec Officer 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Francine Kaufman officer: Chief Medical Officer C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Kenneth L Horton officer: GC & Corp. Development Advisor VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY STREET, CAMBRIDGE MA 02139
Nick B. Tressler officer: Chief Financial Officer C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 208786
Anthony R. Raab director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
John Marotta director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Stephen P Defalco director ONE EXETER STREET, BOSTON MA 02116
Douglas S Prince director 20 TILESTON STREET, PH4, BOSTON MA 02113
Edelman Steven director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876